Core Outcome Domains for Clinical Trials on Somatic Symptom Disorder, Bodily Distress Disorder, and Functional Somatic Syndromes: European Network on Somatic Symptom Disorders Recommendations

被引:89
|
作者
Rief, Winfried [1 ]
Burton, Chris [2 ]
Frostholm, Lisbeth [3 ]
Henningsen, Peter [4 ]
Kleinstaeuber, Maria [5 ]
Kop, Willem J. [6 ]
Loewe, Bernd [7 ]
Martin, Alexandra [8 ]
Malt, Ulrik [9 ]
Rosmalen, Judith [10 ]
Schroder, Andreas [3 ]
Shedden-Mora, Meike [7 ]
Toussaint, Anne [7 ]
van der Feltz-Cornelis, Christina [6 ]
机构
[1] Philipps Univ, Dept Psychol, Marburg, Germany
[2] Univ Aberdeen, Aberdeen, Scotland
[3] Univ Aarhus, Aarhus, Denmark
[4] Tech Univ Munich, Munich, Germany
[5] Univ Marburg, Marburg, Germany
[6] Tilburg Univ, Tilburg, Netherlands
[7] Univ Med Ctr, Hamburg, Germany
[8] Univ Wuppertal, Wuppertal, Germany
[9] Univ Oslo, Oslo, Norway
[10] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
来源
PSYCHOSOMATIC MEDICINE | 2017年 / 79卷 / 09期
关键词
somatic symptom disorder; somatoform; bodily distress; functional somatic syndromes; fibromyalgia; irritable bowel syndrome; ILLNESS PERCEPTION QUESTIONNAIRE; IMMPACT RECOMMENDATIONS; PSYCHOMETRIC PROPERTIES; SOMATOFORM DISORDERS; GENERAL-POPULATION; PHYSICAL SYMPTOMS; PAIN INTENSITY; PLACEBO GROUPS; HEALTH SURVEY; PRIMARY-CARE;
D O I
10.1097/PSY.0000000000000502
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective The harmonization of core outcome domains in clinical trials facilitates comparison and pooling of data, and simplifies the preparation and review of research projects and comparison of risks and benefits of treatments. Therefore, we provide recommendations for the core outcome domains that should be considered in clinical trials on the efficacy and effectiveness of interventions for somatic symptom disorder, bodily distress disorder, and functional somatic syndromes. Methods The European Network on Somatic Symptom Disorders group of more than 20 experts in the field met twice in Hamburg to discuss issues of assessment and intervention research in somatic symptom disorder, bodily distress disorder, and functional somatic syndromes. The consensus meetings identified core outcome domains that should be considered in clinical trials evaluating treatments for somatic symptom disorder and associated functional somatic syndromes. Results The following core domains should be considered when defining ascertainment methods in clinical trials: a) classification of somatic symptom disorder/bodily distress disorder, associated functional somatic syndromes, and comorbid mental disorders (using structured clinical interviews), duration of symptoms, medical morbidity, and prior treatments; b) location, intensity, and interference of somatic symptoms; c) associated psychobehavioral features and biological markers; d) illness consequences (quality of life, disability, health care utilization, health care costs; e) global improvement and treatment satisfaction; and f) unwanted negative effects. Conclusions The proposed criteria are intended to improve synergies of clinical trials and to facilitate decision making when comparing different treatment approaches. These recommendations should not result in inflexible guidelines, but increase consistency across investigations in this field.
引用
收藏
页码:1008 / 1015
页数:8
相关论文
共 50 条
  • [31] Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study
    Haeuser, Winfried
    Hausteiner-Wiehle, Constanze
    Henningsen, Peter
    Braehler, Elmar
    Schmalbach, Bjarne
    Wolfe, Frederick
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2020, 133
  • [32] The distribution of somatic symptom disorder and bodily distress syndrome in general hospital outpatients in China: A multicenter cross-sectional study
    Ma, Dandan
    Cao, Jinya
    Wei, Jing
    Fritzsche, Kurt
    Toussaint, Anne Christin
    Li, Tao
    Zhang, Lan
    Zhang, Yaoyin
    Chen, Hua
    Wu, Heng
    Ma, Xiquan
    Li, Wentian
    Ren, Jie
    Lu, Wei
    Leonhart, Rainer
    GENERAL HOSPITAL PSYCHIATRY, 2023, 85 : 171 - 176
  • [33] Psychobiological Mechanisms in Somatic Symptom Disorder and Depressive Disorders: An Ecological Momentary Assessment Approach
    Mewes, Ricarda
    Feneberg, Anja C.
    Doerr, Johanna M.
    Nater, Urs M.
    PSYCHOSOMATIC MEDICINE, 2022, 84 (01): : 86 - 96
  • [34] Clinical outcomes, medical costs, and medication usage patterns of different somatic symptom disorders and functional somatic syndromes: a population-based study in Taiwan
    Wu, Chi-Shin
    Chen, Tzu-Ting
    Liao, Shih-Cheng
    Huang, Wei-Chia
    Huang, Wei-Lieh
    PSYCHOLOGICAL MEDICINE, 2023, : 1452 - 1460
  • [35] Personality Disorders and Clinical Disorders: The Challenge of Comorbid Autism Spectrum Disorder (ASD), Eating Disorders (EDs), Posttraumatic Stress Disorder (PTSD), or Somatic Symptom Disorder (SSD)
    Links, Paul S.
    Aslam, Hira
    O'Donnell, Mckenna
    CURRENT PSYCHIATRY REPORTS, 2025, 27 (01) : 1 - 9
  • [36] Somatic Symptom Disorder, Medically Unexplained Symptoms, Somatoform Disorders, Functional Neurological Disorder: How DSM-5 Got It Wrong
    Scamvougeras, Anton
    Howard, Andrew
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2020, 65 (05): : 301 - 305
  • [37] Somatic Symptom Disorder Patients Seeking Aesthetic Procedures: Tricky Situations in Clinical Practice
    Wang, Hayson Chenyu
    Wang, Xiaojun
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2020, 8 (12)
  • [38] Efficacy of internet-based cognitive behavioural therapy for somatic symptom disorder and related disorders
    Liu, S.
    He, Z.
    Li, J.
    EPILEPSIA, 2024, 65 : 415 - 415
  • [39] Within- and across-network alterations in the default network and in visual networkpatients with somatic symptom disorder
    Liu, Zhanglihan
    Dong, Liao
    Tang, Wei
    Gao, Tingting
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2022, 327
  • [40] BODILY DISTRESS SYNDROME (BDS) OR FUNCTIONAL SOMATIC SYNDROMES (FSS). A CONDITION WITH A POOR LONG-TERM OUTCOME
    Fink, P.
    Rask, M. T.
    Budtz-Lilly, A.
    Rosendal, M.
    Ornboll, E.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 : S223 - S224